Global and United States Tourette Syndrome Drug In-Depth Research Report 2017-2022

Published: Dec, 2017 | Pages: 105 | Publisher: US Market Insight (UMI)
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Tourette Syndrome Drug industry.

Major Companies
    Abide Therapeutics Inc
    Catalyst Pharmaceuticals Inc
    Neurocrine Biosciences Inc
    Psyadon Pharmaceuticals Inc
    Reviva Pharmaceuticals Inc
    Synchroneuron Inc
    Teva Pharmaceutical Industries Ltd
    Therapix Biosciences Ltd

Key Regions
    North America
        United States
            California
            Texas
            New York
            Others
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Main types of products
Tourette Syndrome Drug Market, byD-5213
Tourette Syndrome Drug Market, byP-115
Tourette Syndrome Drug Market, bytetrabenazine ER
Tourette Syndrome Drug Market, byopipam Hydrochloride
Tourette Syndrome Drug Market, byhers

Tourette Syndrome Drug Market, by Key Consumers
    Research Center
    Hospital
    Clinic
    Others

 Table of Contents

Global and United States Tourette Syndrome Drug In-Depth Research Report 2017-2022
Chapter One Global Tourette Syndrome Drug Market Overview
    1.1 Global Tourette Syndrome Drug Market Sales Volume Revenue and Price 2012-2017
    1.2 Tourette Syndrome Drug, by -5213 2012-2017
        1.2.1 Global Tourette Syndrome Drug Sales Market Share by -5213 2012-2017
        1.2.2 Global Tourette Syndrome Drug Revenue Market Share by -5213 2012-2017
        1.2.3 Global Tourette Syndrome Drug Price by -5213 2012-2017
        1.2.4 
        1.2.5 
    1.3 Tourette Syndrome Drug, by -115 2012-2017
        1.3.1 Global Tourette Syndrome Drug Sales Market Share by -115 2012-2017
        1.3.2 Global Tourette Syndrome Drug Revenue Market Share by -115 2012-2017
        1.3.3 Global Tourette Syndrome Drug Price by -115 2012-2017
        1.3.4 
        1.3.5 
    1.4 Tourette Syndrome Drug, by etrabenazine ER 2012-2017
        1.4.1 Global Tourette Syndrome Drug Sales Market Share by etrabenazine ER 2012-2017
        1.4.2 Global Tourette Syndrome Drug Revenue Market Share by etrabenazine ER 2012-2017
        1.4.3 Global Tourette Syndrome Drug Price by etrabenazine ER 2012-2017
        1.4.4 
        1.4.5 
    1.5 Tourette Syndrome Drug, by pipam Hydrochloride 2012-2017
        1.5.1 Global Tourette Syndrome Drug Sales Market Share by pipam Hydrochloride 2012-2017
        1.5.2 Global Tourette Syndrome Drug Revenue Market Share by pipam Hydrochloride 2012-2017
        1.5.3 Global Tourette Syndrome Drug Price by pipam Hydrochloride 2012-2017
        1.5.4 
        1.5.5 
    1.6 Tourette Syndrome Drug, by ers 2012-2017
        1.6.1 Global Tourette Syndrome Drug Sales Market Share by ers 2012-2017
        1.6.2 Global Tourette Syndrome Drug Revenue Market Share by ers 2012-2017
        1.6.3 Global Tourette Syndrome Drug Price by ers 2012-2017
        1.6.4 
        1.6.5 

Chapter Two United States Tourette Syndrome Drug Market Overview
    2.1 United States Tourette Syndrome Drug Market Sales Volume Revenue and Price 2012-2017
    2.2 Tourette Syndrome Drug, by -5213 2012-2017
        2.2.1 United States Tourette Syndrome Drug Sales Market Share by -5213 2012-2017
        2.2.2 United States Tourette Syndrome Drug Revenue Market Share by -5213 2012-2017
        2.2.3 United States Tourette Syndrome Drug Price by -5213 2012-2017
        2.2.4 
        2.2.5 
    2.3 Tourette Syndrome Drug, by -115 2012-2017
        2.3.1 United States Tourette Syndrome Drug Sales Market Share by -115 2012-2017
        2.3.2 United States Tourette Syndrome Drug Revenue Market Share by -115 2012-2017
        2.3.3 United States Tourette Syndrome Drug Price by -115 2012-2017
        2.3.4 
        2.3.5 
    2.4 Tourette Syndrome Drug, by etrabenazine ER 2012-2017
        2.4.1 United States Tourette Syndrome Drug Sales Market Share by etrabenazine ER 2012-2017
        2.4.2 United States Tourette Syndrome Drug Revenue Market Share by etrabenazine ER 2012-2017
        2.4.3 United States Tourette Syndrome Drug Price by etrabenazine ER 2012-2017
        2.4.4 
        2.4.5 
    2.5 Tourette Syndrome Drug, by pipam Hydrochloride 2012-2017
        2.5.1 United States Tourette Syndrome Drug Sales Market Share by pipam Hydrochloride 2012-2017
        2.5.2 United States Tourette Syndrome Drug Revenue Market Share by pipam Hydrochloride 2012-2017
        2.5.3 United States Tourette Syndrome Drug Price by pipam Hydrochloride 2012-2017
        2.5.4 
        2.5.5 
    2.6 Tourette Syndrome Drug, by ers 2012-2017
        2.6.1 United States Tourette Syndrome Drug Sales Market Share by ers 2012-2017
        2.6.2 United States Tourette Syndrome Drug Revenue Market Share by ers 2012-2017
        2.6.3 United States Tourette Syndrome Drug Price by ers 2012-2017
        2.6.4 
        2.6.5 

Chapter Three Tourette Syndrome Drug by Regions 2012-2017
    3.1 Global Tourette Syndrome Drug Sales Market Share by Regions 2012-2017
    3.2 Global Tourette Syndrome Drug Revenue Market Share by Regions 2012-2017
    3.3 Global Tourette Syndrome Drug Price by Regions 2012-2017
    3.4 North America
        3.4.1 United States
            3.4.1.1 California
            3.4.1.2 Texas
            3.4.1.3 New York
            3.4.1.4 Others in United States
        3.4.2 Canada
    3.5 Latin America
        3.5.1 Mexico
        3.5.2 Brazil
        3.5.3 Argentina
        3.5.4 Others in Latin America
    3.6 Europe
        3.6.1 Germany
        3.6.2 United Kingdom
        3.6.3 France
        3.6.4 Italy
        3.6.5 Spain
        3.6.6 Russia
        3.6.7 Netherland
        3.6.8 Others in Europe
    3.7 Asia & Pacific
        3.7.1 China
        3.7.2 Japan
        3.7.3 India
        3.7.4 Korea
        3.7.5 Australia
        3.7.6 Southeast Asia
            3.7.6.1 Indonesia
            3.7.6.2 Thailand
            3.7.6.3 Philippines
            3.7.6.4 Vietnam
            3.7.6.5 Singapore
            3.7.6.6 Malaysia
            3.7.6.7 Others in Southeast Asia
    3.8 Africa & Middle East
        3.8.1 South Africa
        3.8.2 Egypt
        3.8.3 Turkey
        3.8.4 Saudi Arabia
        3.8.5 Iran
        3.8.6 Others in Africa & Middle East

Chapter Four Global Tourette Syndrome Drug by Companies 2012-2017
    4.1 Global Tourette Syndrome Drug Sales Volume Market Share by Companies 2012-2017
    4.2 Global Tourette Syndrome Drug Revenue Share by Companies 2012-2017
    4.3 Global Top Companies Tourette Syndrome Drug Key Product Model and Market Performance
    4.4 Global Top Companies Tourette Syndrome Drug Key Target Consumers and Market Performance

Chapter Five United States Tourette Syndrome Drug by Companies 2012-2017
    5.1 United States Tourette Syndrome Drug Sales Volume Market Share by Companies 2012-2017
    5.2 United States Tourette Syndrome Drug Revenue Share by Companies 2012-2017
    5.3 United States Top Companies Tourette Syndrome Drug Key Product Model and Market Performance
    5.4 United States Top Companies Tourette Syndrome Drug Key Target Consumers and Market Performance

Chapter Six Global Tourette Syndrome Drug by Consumer 2012-2017
    6.1 Global Tourette Syndrome Drug Sales Market Share by Consumer 2012-2017
    6.2 Research Center
    6.3 Hospital
    6.4 Clinic
    6.5 Others
    6.6 Consuming Habit and Preference

Chapter Seven Global Tourette Syndrome Drug by Consumer 2012-2017
    7.1 Global Tourette Syndrome Drug Sales Market Share by Consumer 2012-2017
    7.2 Research Center
    7.3 Hospital
    7.4 Clinic
    7.5 Others
    7.6 Consuming Habit and Preference

Chapter Eight Top Companies Profile
    8.1 Abide Therapeutics Inc
        8.1.1 Abide Therapeutics Inc Company Details and Competitors
        8.1.2 Abide Therapeutics Inc Key Tourette Syndrome Drug Models and Performance
        8.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Business SWOT Analysis and Forecast
        8.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.2 Catalyst Pharmaceuticals Inc
        8.2.1 Catalyst Pharmaceuticals Inc Company Details and Competitors
        8.2.2 Catalyst Pharmaceuticals Inc Key Tourette Syndrome Drug Models and Performance
        8.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Business SWOT Analysis and Forecast
        8.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.3 Neurocrine Biosciences Inc
        8.3.1 Neurocrine Biosciences Inc Company Details and Competitors
        8.3.2 Neurocrine Biosciences Inc Key Tourette Syndrome Drug Models and Performance
        8.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Business SWOT Analysis and Forecast
        8.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.4 Psyadon Pharmaceuticals Inc
        8.4.1 Psyadon Pharmaceuticals Inc Company Details and Competitors
        8.4.2 Psyadon Pharmaceuticals Inc Key Tourette Syndrome Drug Models and Performance
        8.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Business SWOT Analysis and Forecast
        8.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.5 Reviva Pharmaceuticals Inc
        8.5.1 Reviva Pharmaceuticals Inc Company Details and Competitors
        8.5.2 Reviva Pharmaceuticals Inc Key Tourette Syndrome Drug Models and Performance
        8.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Business SWOT Analysis and Forecast
        8.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.6 Synchroneuron Inc
        8.6.1 Synchroneuron Inc Company Details and Competitors
        8.6.2 Synchroneuron Inc Key Tourette Syndrome Drug Models and Performance
        8.6.3 Synchroneuron Inc Tourette Syndrome Drug Business SWOT Analysis and Forecast
        8.6.4 Synchroneuron Inc Tourette Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.7 Teva Pharmaceutical Industries Ltd
        8.7.1 Teva Pharmaceutical Industries Ltd Company Details and Competitors
        8.7.2 Teva Pharmaceutical Industries Ltd Key Tourette Syndrome Drug Models and Performance
        8.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Business SWOT Analysis and Forecast
        8.7.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin
    8.8 Therapix Biosciences Ltd
        8.8.1 Therapix Biosciences Ltd Company Details and Competitors
        8.8.2 Therapix Biosciences Ltd Key Tourette Syndrome Drug Models and Performance
        8.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Business SWOT Analysis and Forecast
        8.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Sales Volume Revenue Price Cost and Gross Margin

Chapter Nine Industry Chain and Supply Chain
    9.1 Tourette Syndrome Drug Industry Chain Structure
        9.1.1 R&D
        9.1.2 Raw Materials (Components)
        9.1.3 Manufacturing Plants
        9.1.4 Regional Trading (Import Export and Local Sales)
        9.1.5 Online Sales Channel
        9.1.6 Offline Channel
        9.1.7 End Users
    9.2 Tourette Syndrome Drug Manufacturing
        9.2.1 Key Components
        9.2.2 Assembly Manufacturing
    9.3 Consumer Preference
    9.4 Behavioral Habits
    9.5 Marketing Environment

Chapter Ten Global Tourette Syndrome Drug Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Tourette Syndrome Drug Sales (K Pcs) Forecast by Regions (2017-2022)
    10.3 Global Tourette Syndrome Drug Sales (K Pcs) Forecast by Application (2017-2022)
    10.4 Global Tourette Syndrome Drug Sales (K Pcs) Forecast by -5213 (2017-2022)
    10.5 Global Tourette Syndrome Drug Sales (K Pcs) Forecast by -115 (2017-2022)
    10.6 Global Tourette Syndrome Drug Sales (K Pcs) Forecast by etrabenazine ER (2017-2022)
    10.7 Global Tourette Syndrome Drug Sales (K Pcs) Forecast by pipam Hydrochloride (2017-2022)
    10.8 Global Tourette Syndrome Drug Sales (K Pcs) Forecast by ers (2017-2022)

Chapter Eleven United States Tourette Syndrome Drug Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 United States Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    11.2 United States Tourette Syndrome Drug Sales (K Pcs) Forecast by Regions (2017-2022)
    11.3 United States Tourette Syndrome Drug Sales (K Pcs) Forecast by Application (2017-2022)
    11.4 United States Tourette Syndrome Drug Sales (K Pcs) Forecast by -5213 (2017-2022)
    11.5 United States Tourette Syndrome Drug Sales (K Pcs) Forecast by -115 (2017-2022)
    11.6 United States Tourette Syndrome Drug Sales (K Pcs) Forecast by etrabenazine ER (2017-2022)
    11.7 United States Tourette Syndrome Drug Sales (K Pcs) Forecast by pipam Hydrochloride (2017-2022)
    11.8 United States Tourette Syndrome Drug Sales (K Pcs) Forecast by ers (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
    12.1 Development Trend
    12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Table Global Tourette Syndrome Drug Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Global Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Tourette Syndrome Drug Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Global Tourette Syndrome Drug Sales (K Pcs) by -5213 (2012-2017)
    Table Global Tourette Syndrome Drug Sales Market Share by -5213 (2012-2017)
    Figure Global Tourette Syndrome Drug Sales Market Share by -5213 in 2016
    Table Global Tourette Syndrome Drug Revenue (Million USD) by -5213 (2012-2017)
    Table Global Tourette Syndrome Drug Revenue Market Share by -5213 (2012-2017)
    Figure Global Tourette Syndrome Drug Revenue Market Share by -5213 in 2016
    Table Global Tourette Syndrome Drug Price (USD/Pcs) by -5213 (2012-2017)
    Table Global Tourette Syndrome Drug Sales (K Pcs) by -115 (2012-2017)
    Table Global Tourette Syndrome Drug Sales Market Share by -115 (2012-2017)
    Figure Global Tourette Syndrome Drug Sales Market Share by -115 in 2016
    Table Global Tourette Syndrome Drug Revenue (Million USD) by -115 (2012-2017)
    Table Global Tourette Syndrome Drug Revenue Market Share by -115 (2012-2017)
    Figure Global Tourette Syndrome Drug Revenue Market Share by -115 in 2016
    Table Global Tourette Syndrome Drug Price (USD/Pcs) by -115 (2012-2017)
    Table Global Tourette Syndrome Drug Sales (K Pcs) by etrabenazine ER (2012-2017)
    Table Global Tourette Syndrome Drug Sales Market Share by etrabenazine ER (2012-2017)
    Figure Global Tourette Syndrome Drug Sales Market Share by etrabenazine ER in 2016
    Table Global Tourette Syndrome Drug Revenue (Million USD) by etrabenazine ER (2012-2017)
    Table Global Tourette Syndrome Drug Revenue Market Share by etrabenazine ER (2012-2017)
    Figure Global Tourette Syndrome Drug Revenue Market Share by etrabenazine ER in 2016
    Table Global Tourette Syndrome Drug Price (USD/Pcs) by etrabenazine ER (2012-2017)
    Table Global Tourette Syndrome Drug Sales (K Pcs) by pipam Hydrochloride (2012-2017)
    Table Global Tourette Syndrome Drug Sales Market Share by pipam Hydrochloride (2012-2017)
    Figure Global Tourette Syndrome Drug Sales Market Share by pipam Hydrochloride in 2016
    Table Global Tourette Syndrome Drug Revenue (Million USD) by pipam Hydrochloride (2012-2017)
    Table Global Tourette Syndrome Drug Revenue Market Share by pipam Hydrochloride (2012-2017)
    Figure Global Tourette Syndrome Drug Revenue Market Share by pipam Hydrochloride in 2016
    Table Global Tourette Syndrome Drug Price (USD/Pcs) by pipam Hydrochloride (2012-2017)
    Table Global Tourette Syndrome Drug Sales (K Pcs) by ers (2012-2017)
    Table Global Tourette Syndrome Drug Sales Market Share by ers (2012-2017)
    Figure Global Tourette Syndrome Drug Sales Market Share by ers in 2016
    Table Global Tourette Syndrome Drug Revenue (Million USD) by ers (2012-2017)
    Table Global Tourette Syndrome Drug Revenue Market Share by ers (2012-2017)
    Figure Global Tourette Syndrome Drug Revenue Market Share by ers in 2016
    Table Global Tourette Syndrome Drug Price (USD/Pcs) by ers (2012-2017)
    Figure United States Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure United States Tourette Syndrome Drug Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table United States Tourette Syndrome Drug Sales (K Pcs) by -5213 (2012-2017)
    Table United States Tourette Syndrome Drug Sales Market Share by -5213 (2012-2017)
    Figure United States Tourette Syndrome Drug Sales Market Share by -5213 in 2016
    Table United States Tourette Syndrome Drug Revenue (Million USD) by -5213 (2012-2017)
    Table United States Tourette Syndrome Drug Revenue Market Share by -5213 (2012-2017)
    Figure United States Tourette Syndrome Drug Revenue Market Share by -5213 in 2016
    Table United States Tourette Syndrome Drug Price (USD/Pcs) by -5213 (2012-2017)
    Table United States Tourette Syndrome Drug Sales (K Pcs) by -115 (2012-2017)
    Table United States Tourette Syndrome Drug Sales Market Share by -115 (2012-2017)
    Figure United States Tourette Syndrome Drug Sales Market Share by -115 in 2016
    Table United States Tourette Syndrome Drug Revenue (Million USD) by -115 (2012-2017)
    Table United States Tourette Syndrome Drug Revenue Market Share by -115 (2012-2017)
    Figure United States Tourette Syndrome Drug Revenue Market Share by -115 in 2016
    Table United States Tourette Syndrome Drug Price (USD/Pcs) by -115 (2012-2017)
    Table United States Tourette Syndrome Drug Sales (K Pcs) by etrabenazine ER (2012-2017)
    Table United States Tourette Syndrome Drug Sales Market Share by etrabenazine ER (2012-2017)
    Figure United States Tourette Syndrome Drug Sales Market Share by etrabenazine ER in 2016
    Table United States Tourette Syndrome Drug Revenue (Million USD) by etrabenazine ER (2012-2017)
    Table United States Tourette Syndrome Drug Revenue Market Share by etrabenazine ER (2012-2017)
    Figure United States Tourette Syndrome Drug Revenue Market Share by etrabenazine ER in 2016
    Table United States Tourette Syndrome Drug Price (USD/Pcs) by etrabenazine ER (2012-2017)
    Table United States Tourette Syndrome Drug Sales (K Pcs) by pipam Hydrochloride (2012-2017)
    Table United States Tourette Syndrome Drug Sales Market Share by pipam Hydrochloride (2012-2017)
    Figure United States Tourette Syndrome Drug Sales Market Share by pipam Hydrochloride in 2016
    Table United States Tourette Syndrome Drug Revenue (Million USD) by pipam Hydrochloride (2012-2017)
    Table United States Tourette Syndrome Drug Revenue Market Share by pipam Hydrochloride (2012-2017)
    Figure United States Tourette Syndrome Drug Revenue Market Share by pipam Hydrochloride in 2016
    Table United States Tourette Syndrome Drug Price (USD/Pcs) by pipam Hydrochloride (2012-2017)
    Table United States Tourette Syndrome Drug Sales (K Pcs) by ers (2012-2017)
    Table United States Tourette Syndrome Drug Sales Market Share by ers (2012-2017)
    Figure United States Tourette Syndrome Drug Sales Market Share by ers in 2016
    Table United States Tourette Syndrome Drug Revenue (Million USD) by ers (2012-2017)
    Table United States Tourette Syndrome Drug Revenue Market Share by ers (2012-2017)
    Figure United States Tourette Syndrome Drug Revenue Market Share by ers in 2016
    Table United States Tourette Syndrome Drug Price (USD/Pcs) by ers (2012-2017)
    Table Global Tourette Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table Global Tourette Syndrome Drug Sales Share by Regions (2012-2017)
    Figure Global Tourette Syndrome Drug Sales Market Share by Regions in 2016
    Figure Global Tourette Syndrome Drug Sales Market Share by Regions in 2017
    Table Global Tourette Syndrome Drug Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table Global Tourette Syndrome Drug Revenue Market Share by Regions (2012-2017)
    Figure Global Tourette Syndrome Drug Revenue Market Share by Regions in 2016
    Figure Global Tourette Syndrome Drug Revenue Market Share by Regions in 2017
    Table Global Tourette Syndrome Drug Price (USD/Pcs) by Regions (2012-2017)
    Table North America Tourette Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table North America Tourette Syndrome Drug Revenue (Million USD) by Regions (2012-2017)
    Figure North America Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Tourette Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table United States Tourette Syndrome Drug Revenue (Million USD) by Regions (2012-2017)
    Figure United States Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Latin America Tourette Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table Latin America Tourette Syndrome Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Tourette Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table Europe Tourette Syndrome Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Asia & Pacific Tourette Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table Asia & Pacific Tourette Syndrome Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Africa & Middle East Tourette Syndrome Drug Sales (K Pcs) by Regions (2012-2017)
    Table Africa & Middle East Tourette Syndrome Drug Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Tourette Syndrome Drug Sales Volume (K Pcs) by Major Companies (2012-2017)
    Table Global Tourette Syndrome Drug Sales Volume Market Share by Major Companies (2012-2017)
    Figure Global Tourette Syndrome Drug Sales Volume Market Share by Major Companies 2016
    Figure Global Tourette Syndrome Drug Sales Volume Market Share by Major Companies 2017
    Table Global Tourette Syndrome Drug Revenue (Million USD) by Major Companies (2012-2017)
    Table Global Tourette Syndrome Drug Revenue Market Share by Major Companies (2012-2017)
    Figure Global Tourette Syndrome Drug Revenue Market Share by Major Companies 2016
    Figure Global Tourette Syndrome Drug Revenue Market Share by Major Companies 2017
    Table Global Top Companies Key Product Model and Market Performance
    Table Global Top Companies Key Target Consumers and Market Performance
    Table United States Tourette Syndrome Drug Sales Volume (K Pcs) by Top Companies (2012-2017)
    Table United States Tourette Syndrome Drug Sales Volume Market Share by Top Companies (2012-2017)
    Figure United States Tourette Syndrome Drug Sales Volume Market Share by Top Companies 2016
    Figure United States Tourette Syndrome Drug Sales Volume Market Share by Top Companies 2017
    Table United States Tourette Syndrome Drug Revenue (Million USD) by Top Companies (2012-2017)
    Table United States Tourette Syndrome Drug Revenue Market Share by Top Companies (2012-2017)
    Figure United States Tourette Syndrome Drug Revenue Market Share by Top Companies 2016
    Figure United States Tourette Syndrome Drug Revenue Market Share by Top Companies 2017
    Table United States Top Companies Key Product Model and Market Performance
    Table United States Top Companies Key Target Consumers and Market Performance
    Table Global Tourette Syndrome Drug Sales (K Pcs) by Consumer (2012-2017)
    Figure Global Tourette Syndrome Drug Sales Market Share by Consumer (2012-2017)
    Figure Global Tourette Syndrome Drug Sales Market Share by Consumer in 2016
    Figure Global Research Center Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Hospital Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Clinic Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Others Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table United States Tourette Syndrome Drug Sales (K Pcs) by Consumer (2012-2017)
    Figure United States Tourette Syndrome Drug Sales Market Share by Consumer (2012-2017)
    Figure United States Tourette Syndrome Drug Sales Market Share by Consumer in 2016
    Figure United States Research Center Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Hospital Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Clinic Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure United States Others Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Table Abide Therapeutics Inc Company Details and Competitors
    Table Abide Therapeutics Inc Key Tourette Syndrome Drug Models and Performance
    Table Abide Therapeutics Inc Tourette Syndrome Drug Business SWOT Analysis and Forecast
    Table Abide Therapeutics Inc Tourette Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Abide Therapeutics Inc Tourette Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Abide Therapeutics Inc Tourette Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Abide Therapeutics Inc Tourette Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Abide Therapeutics Inc Tourette Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table Catalyst Pharmaceuticals Inc Company Details and Competitors
    Table Catalyst Pharmaceuticals Inc Key Tourette Syndrome Drug Models and Performance
    Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Business SWOT Analysis and Forecast
    Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table Neurocrine Biosciences Inc Company Details and Competitors
    Table Neurocrine Biosciences Inc Key Tourette Syndrome Drug Models and Performance
    Table Neurocrine Biosciences Inc Tourette Syndrome Drug Business SWOT Analysis and Forecast
    Table Neurocrine Biosciences Inc Tourette Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table Psyadon Pharmaceuticals Inc Company Details and Competitors
    Table Psyadon Pharmaceuticals Inc Key Tourette Syndrome Drug Models and Performance
    Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Business SWOT Analysis and Forecast
    Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table Reviva Pharmaceuticals Inc Company Details and Competitors
    Table Reviva Pharmaceuticals Inc Key Tourette Syndrome Drug Models and Performance
    Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Business SWOT Analysis and Forecast
    Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table Synchroneuron Inc Company Details and Competitors
    Table Synchroneuron Inc Key Tourette Syndrome Drug Models and Performance
    Table Synchroneuron Inc Tourette Syndrome Drug Business SWOT Analysis and Forecast
    Table Synchroneuron Inc Tourette Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Synchroneuron Inc Tourette Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Synchroneuron Inc Tourette Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Synchroneuron Inc Tourette Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Synchroneuron Inc Tourette Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table Teva Pharmaceutical Industries Ltd Company Details and Competitors
    Table Teva Pharmaceutical Industries Ltd Key Tourette Syndrome Drug Models and Performance
    Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Business SWOT Analysis and Forecast
    Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Table Therapix Biosciences Ltd Company Details and Competitors
    Table Therapix Biosciences Ltd Key Tourette Syndrome Drug Models and Performance
    Table Therapix Biosciences Ltd Tourette Syndrome Drug Business SWOT Analysis and Forecast
    Table Therapix Biosciences Ltd Tourette Syndrome Drug Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Therapix Biosciences Ltd Tourette Syndrome Drug Sales (Million Unit) and Growth Rate (%)(2012-2017)
    Figure Therapix Biosciences Ltd Tourette Syndrome Drug Sales Market Share (%) in Global (2012-2017)
    Figure Therapix Biosciences Ltd Tourette Syndrome Drug Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
    Figure Therapix Biosciences Ltd Tourette Syndrome Drug Revenue Market Share (%) in Global (2012-2017)
    Figure Global Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Tourette Syndrome Drug Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Global Tourette Syndrome Drug Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global Tourette Syndrome Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Tourette Syndrome Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Tourette Syndrome Drug Sales Volume Share Forecast by Regions in 2022
    Table Global Tourette Syndrome Drug Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global Tourette Syndrome Drug Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Tourette Syndrome Drug Sales Volume Market Share Forecast by Application in 2022
    Table Global Tourette Syndrome Drug Sales (K Pcs) Forecast by -5213 (2017-2022)
    Figure Global Tourette Syndrome Drug Sales (K Pcs) Forecast by -5213 (2017-2022)
    Figure Global Tourette Syndrome Drug Sales Volume Market Share Forecast by -5213 in 2022
    Table Global Tourette Syndrome Drug Sales (K Pcs) Forecast by -115 (2017-2022)
    Figure Global Tourette Syndrome Drug Sales (K Pcs) Forecast by -115 (2017-2022)
    Figure Global Tourette Syndrome Drug Sales Volume Market Share Forecast by -115 in 2022
    Table Global Tourette Syndrome Drug Sales (K Pcs) Forecast by etrabenazine ER (2017-2022)
    Figure Global Tourette Syndrome Drug Sales (K Pcs) Forecast by etrabenazine ER (2017-2022)
    Figure Global Tourette Syndrome Drug Sales Volume Market Share Forecast by etrabenazine ER in 2022
    Table Global Tourette Syndrome Drug Sales (K Pcs) Forecast by pipam Hydrochloride (2017-2022)
    Figure Global Tourette Syndrome Drug Sales (K Pcs) Forecast by pipam Hydrochloride (2017-2022)
    Figure Global Tourette Syndrome Drug Sales Volume Market Share Forecast by pipam Hydrochloride in 2022
    Table Global Tourette Syndrome Drug Sales (K Pcs) Forecast by ers (2017-2022)
    Figure Global Tourette Syndrome Drug Sales (K Pcs) Forecast by ers (2017-2022)
    Figure Global Tourette Syndrome Drug Sales Volume Market Share Forecast by ers in 2022
    Figure United States Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure United States Tourette Syndrome Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Tourette Syndrome Drug Price (USD/Pcs) Trend Forecast (2017-2022)
    Table United States Tourette Syndrome Drug Sales (K Pcs) Forecast by Regions (2017-2022)
    Table United States Tourette Syndrome Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Tourette Syndrome Drug Sales Volume Share Forecast by Regions (2017-2022)
    Figure United States Tourette Syndrome Drug Sales Volume Share Forecast by Regions in 2022
    Table United States Tourette Syndrome Drug Sales (K Pcs) Forecast by Application (2017-2022)
    Figure United States Tourette Syndrome Drug Sales Volume Market Share Forecast by Application (2017-2022)
    Figure United States Tourette Syndrome Drug Sales Volume Market Share Forecast by Application in 2022
    Table United States Tourette Syndrome Drug Sales (K Pcs) Forecast by -5213 (2017-2022)
    Figure United States Tourette Syndrome Drug Sales (K Pcs) Forecast by -5213 (2017-2022)
    Figure United States Tourette Syndrome Drug Sales Volume Market Share Forecast by -5213 in 2022
    Table United States Tourette Syndrome Drug Sales (K Pcs) Forecast by -115 (2017-2022)
    Figure United States Tourette Syndrome Drug Sales (K Pcs) Forecast by -115 (2017-2022)
    Figure United States Tourette Syndrome Drug Sales Volume Market Share Forecast by -115 in 2022
    Table United States Tourette Syndrome Drug Sales (K Pcs) Forecast by etrabenazine ER (2017-2022)
    Figure United States Tourette Syndrome Drug Sales (K Pcs) Forecast by etrabenazine ER (2017-2022)
    Figure United States Tourette Syndrome Drug Sales Volume Market Share Forecast by etrabenazine ER in 2022
    Table United States Tourette Syndrome Drug Sales (K Pcs) Forecast by pipam Hydrochloride (2017-2022)
    Figure United States Tourette Syndrome Drug Sales (K Pcs) Forecast by pipam Hydrochloride (2017-2022)
    Figure United States Tourette Syndrome Drug Sales Volume Market Share Forecast by pipam Hydrochloride in 2022
    Table United States Tourette Syndrome Drug Sales (K Pcs) Forecast by ers (2017-2022)
    Figure United States Tourette Syndrome Drug Sales (K Pcs) Forecast by ers (2017-2022)
    Figure United States Tourette Syndrome Drug Sales Volume Market Share Forecast by ers in 2022